Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Subscribe and saveSummer Special! Upgrade here at £1.99/m (50% OFF!)

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
AI
Tech
Science

Regeneron
Health
Cancer
Obesity
Reproductive Health
Mental Health
Topics

Advertisement

Regeneron

Share

Top Latest Popular

BIOCON launches aflibercept biosimilar in the United States

JD Supra 3d

Regeneron podcast turns science learnings into immersive experience

FiercePharma 3d

Ninth circuit revives Regeneron Kickback whistleblower lawsuit

Bloomberg Law 5d

Advertisement

Advertisement

Pasatru’s FDA Approval Puts Regeneron’s Rare-Disease Playbook To The Test

Scrip Pharma Intelligence 5d

Regeneron’s uveitis setback adds to string of recent pipeline challenges

Scrip Pharma Intelligence 5d

Spotlight on: Biosimilar litigations - August 2026

JD Supra 7d

EyePoint's drug for age-related eye disease fails late-stage trial, shares tank 70%

The Economic Times 7d

Action alleging drug company Kickback scheme is revived

Metropolitan News-Enterprise, Los Angeles 3d

Advertisement

Advertisement

Advertisement

Regeneron News

Latest news and updates on Regeneron Pharmaceuticals, an American biotechnology company that was founded in 1988. The company is listed on NASDAQ.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Health Health
Back to Lifestyle Health
- Cancer Cancer
- Infectious Diseases
- Mental Health
- Neurological Diseases
- Obesity Obesity
- Rare Diseases
- Reproductive Health